Drugs / GSK3191607
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02737007 | Apr → May 2016 | Plasmodium falciparum malaria | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GSK3191607 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02737007 ↗ |
| Route | Intravenous | “administered intravenously as a single dose infusion over 15 minutes” NCT02737007 ↗ |